Jenner Technologies
3Patents
0Active
3Granted
23Portfolio score
Filing activity: Aug 10, 1994 → Jun 7, 1995
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5925362A | Method to elicit an antitumor response with human prostate-specific antigen | Emerging Cross-Sectional Technologies | 29 | Expired |
| US5820880A | Liposomal formulation | Emerging Cross-Sectional Technologies | 20 | Expired |
| US5738867A | Antitumor vaccines | Emerging Cross-Sectional Technologies | 15 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.